Patent application number | Description | Published |
20080274702 | Method and Device for Measuring Radio Interference Levels With Frequency Tracking - The invention relates to a method for measuring radio interference levels in a specific frequency range. Said method consists in adjusting the frequency range by means of a pre-measurement; respectively detecting, for each measuring frequency one measuring level of the signal which is to be measured; comparing the measured measuring level to the threshold value, characterised in that when the threshold value of the measuring level is exceeded, the measured level is compared to the respective measuring frequency as a radio interference level; and measuring, in a post-measurement phase, each characterised radio interference level in a more precise manner and in relation to the runtime performance thereof. The average frequency of the measuring frequency range of post-measurement, which is repeated in an alternating cyclic manner in relation to the post-measurement, is tracked in relation to the average frequency of the variable radio interference level which was recently determined in previous pre-measurement, for each characterised radio interference level. | 11-06-2008 |
20140095116 | MEASURING DEVICE AND A MEASURING METHOD WITH COUPLED DISPLAY - A measuring device according to the invention comprises at least a first detector and a second detector for detecting a signal. It further comprises a control device and a display device. In this context, the control device is set up to cause the first detector and/or the second detector to be supplied with the first signal. The control device is further set up to selectively display the signal detected by the first detector by means of the display device in a first display region and in a second display region when a user entry determines a display in one of the display regions, and/or to display the signal detected by the second detector by means of the display device in the first display region and in the second display region when a user entry determines a display in one of the display regions. | 04-03-2014 |
20140358477 | MEASURING DEVICE AND METHOD FOR AUTOMATIC ADJUSTMENT OF CONTRAST IN THE SCREEN DISPLAY - A measuring device is used to increase a contrast of a plurality of measured values displayed in a spectrogram or spectral histogram and contains a data-acquisition unit, a computer unit and a statistic unit. The data-acquisition unit is embodied to detect a plurality of measured values to be displayed. The statistic unit is embodied to calculate a distribution which contains the frequency of occurrence for every level value of the measured values to be displayed. The computer unit is embodied to specify a dynamic range, over which the contrast extends. In this context, a specified proportion of the level values which image the noise are not used for the specification of the dynamic range. | 12-04-2014 |
Patent application number | Description | Published |
20120115138 | METHOD FOR IN VITRO DIAGNOSING A COMPLEX DISEASE - The present invention relates to a method and kit for in vitro diagnosing a complex disease such as cancer, in particular, acute myeloid leukemia (AML), colon cancer, kidney cancer, prostate cancer; transient ischemic attack (TIA), ischemia, in particular stroke, hypoxia, hypoxic-ischemic encephalopathy, perinatal brain damage, hypoxic-ischemic encephalopathy of neotatals asphyxia; demyelinating disease, in particular, white-matter disease, periventricular leukoencephalopathy, multiple sclerosis, Alzheimer and Parkinson's disease; in a biological sample. For the diagnosis, use is made of measuring at least two different species of biomolecules and classifying the results by means of suitable classifier algorithms and other statistical procedures. With the present invention, a significant improvement of the reliability of e.g. expression profiles alone, are achieved. In other words, in a defined collective, an up to 100% accurate positive diagnosis could be achieved, which renders the method of the present invention superior over the prior art. | 05-10-2012 |
20120136581 | Method of Diagnosing Asphyxia - A method for in vitro diagnosing asphyxia and disorders related thereto, a method of in vitro estimating duration of hypoxia in a patient subjected to asphyxia, and a method for in vitro monitoring of normoxic, hypoxic and hyperoxic conditions and/or normobaric and hyperbaric oxygen therapy, includes quantitatively detecting in a biological sample of a patient a plurality of asphyxia specific endogenous compounds which are selected from the group consisting of biogenic amines; carnitine-derived compounds; amino acids; bile acids; carboxylic acids; eicosanoids; lipids; precursors of cholesterol, cholesterol metabolites; prostanoids; and sugars. | 05-31-2012 |
20120202240 | Method for Predicting the likelihood of an Onset of an Inflammation Associated Organ Failure - The present invention relates to a reliable and statistically significant method for predicting the likelihood of an onset of an inflammation associated organ failure from a biological sample of a mammalian subject in vitro, by means of a subject's quantitative metabolomics profile comprising a plurality of endogenous metabolites, and comparing it with a quantitative reference metabolomics profile of a plurality of endogenous organ failure predictive target metabolites in order to predict whether the subject is likely or unlikely to develop an organ failure. Furthermore, the invention relates to the usefulness of endogenous organ failure predictive target metabolites in such a method. | 08-09-2012 |
20120208282 | Method For Normalization in Metabolomics Analysis Methods with Endogenous Reference Metabolites. - The present invention relates to the use of endogenous reference metabolites and a method for normalization of intensity data corresponding to amounts and/or concentrations of selected target metabolites in a biological sample of a mammalian subject, wherein said intensity data are obtained by a metabolomics analysis method with one or a plurality of endogenous reference metabolites, comprising carrying out at least one in vitro metabolomics analysis method of said selected target metabolites in said biological sample, simultaneously carrying out in the same sample a quantitative analysis of one or a plurality of endogenous reference metabolites or derivatives thereof, wherein said endogenous reference metabolites are such compounds in the biological sample which are present in the subject at an essentially constant level; and wherein said endogenous reference metabolites or derivatives thereof have a molecular mass less than 1500 Da. | 08-16-2012 |
20140297195 | Method and Use of Metabolites for the Diagnosis of Inflammatory Brain Injury in Preterm Born Infants - The present invention relates to novel biomarkers for predicting the likelihood of inflammation-related brain injury in preterm born infants, using a plurality of endogenous target metabolites selected from the group consisting of acyl carnitins, diacylphosphatidylcholines, acyl-alkylphosphatidylchoines, lysophosphatidylcholines and amino acids. | 10-02-2014 |
20140308687 | Method and Use of Metabolites for the Diagnosis and Differentiation of Neonatal Encephalopathy - Metabolites and signatures (panels) of metabolites are applicable as biomarkers in clinical diagnosis, in particular for neonatal encephalopathy. They are useful tools in differential clinical diagnosis for early detection of brain injury, determination of brain areas affected by the insults and prediction of adverse neurological outcome and may also be applied in diagnosing disease progression and treatment effect. An in vitro method for predicting the likelihood of neonatal encephalopathy of distinct brain areas, identification of affected brain area(s) of neonatal encephalopathy and risk of brain damage and prognosis and neurological outcome due to identification of the type and extent of damage of distinct brain tissues, in particular of hippocampus and/or basal ganglia, is provided. | 10-16-2014 |